Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.73% | 132.98 | 0.7% | $891.71m | |
| PFE | Pfizer Inc. | 0.70% | 36.56 | 0.9% | $665.55m | |
| MRK | Merck & Co., Inc. | 0.41% | 85.04 | 0.7% | $648.50m | |
| ABBV | AbbVie, Inc. | 1.27% | 74.70 | 2.3% | $559.10m | |
| BMY | Bristol-Myers Squibb Company | 0.83% | 51.99 | 1.4% | $509.35m | |
| LLY | Eli Lilly and Company | 1.65% | 109.68 | 1.0% | $310.36m | |
| NVS | Novartis AG Sponsored ADR | 0.92% | 86.72 | 0.2% | $147.83m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.79% | 44.19 | 1.2% | $144.54m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.32% | 42.31 | 0.3% | $93.72m | |
| SNY | Sanofi Sponsored ADR | 1.52% | 45.57 | 0.2% | $81.63m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 0.94% | 52.52 | 0.1% | $72.50m | |
| LCI | Lannett Company, Inc. | 3.65% | 11.22 | 35.6% | $16.60m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -2.24% | 1.75 | 1.6% | $0.56m | |
| EPIX | ESSA Pharma Inc | 3.64% | 3.42 | 0.1% | $0.10m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.